bibliographicCitation |
Martins AS, Mackintosh C, Martín DH, Campos M, Hernández T, Ordóñez JL, de Alava E. Insulin-like growth factor I receptor pathway inhibition by ADW742, alone or in combination with imatinib, doxorubicin, or vincristine, is a novel therapeutic approach in Ewing tumor. Clin Cancer Res. 2006 Jun 01;12(11 Pt 1):3532–40. doi: 10.1158/1078-0432.ccr-05-1778. PMID: 16740780. |